Nichetti, Federico http://orcid.org/0000-0001-8044-4207
Marra, Antonio
Corti, Francesca
Guidi, Alessandro
Raimondi, Alessandra
Prinzi, Natalie
de Braud, Filippo
Pusceddu, Sara
Article History
First Online: 14 April 2018
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this manuscript.
: Filippo de Braud has been the principal investigator of a Phase I trial testing BMS-986148 granted by BMS. He also has taken part to advisory boards of BMS, IGNYTA, Daiichi Sankyo, Novartis, Amgen, and received speaker honoraria from BMS, Eli Lilly, Roche, Amgen, and Novartis. Federico Nichetti, Antonio Marra, Francesca Corti, Alessandro Guidi, Alessandra Raimondi, Natalie Prinzi, and Sara Pusceddu declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.